 |
市場調查報告書
商品編碼
2029908
全球核酸萃取純化市場：按產品、方法、類型、樣品類型、應用、最終用戶和地區分類－預測至2030年Nucleic Acid Isolation and Purification Market by Product, Method, Type, Application, End User, Region - Global Forecast to 2030 |
||||||
價格
預計核酸萃取和純化市場在預測期內將以 9.1% 的複合年成長率成長，從 2025 年的 71 億美元成長到 2030 年的 109.9 億美元。
| 調查範圍 | |
|---|---|
| 調查期 | 2024-2030 |
| 基準年 | 2024 |
| 預測期 | 2025-2030 |
| 目標單元 | 金額（10億美元） |
| 部分 | 按產品、方法、類型、樣品類型、應用、最終用戶和地區分類。 |
| 目標區域 | 北美、歐洲、亞太地區、拉丁美洲、中東和非洲 |
PCR 和其他核酸擴增檢測 (NAAT) 流程已在許多感染疾病控制計畫中常規進行。檢查室正在擴展檢測項目並處理更大的檢體量。新一代定序 (NGS) 工具在臨床應用中也日益普及，而作為第一步，對高純度 DNA/RNA 的需求不斷成長。提取品質差會影響下游流程的靈敏度。因此，我們鼓勵終端用戶繼續投資於可靠的核酸擴增檢測流程和試劑。
“在2024年的核酸萃取和純化市場中，使用磁珠進行分離和純化的方法將佔據最大的市場佔有率。”
核酸分離純化市場可分為磁珠分離純化、管柱分離純化、試劑分離純化等方法。 2024年，磁珠分離純化方法佔市場主導地位。其優勢主要體現在與自動化和高通量處理的兼容性上，而這些正是醫院、實驗室和大規模研究中心所優先考慮的。此外，基於磁珠的方法能夠確保批次間產量和重複性的一致性，從而幫助檢查室減少重複檢測並縮短處理時間。
“到2024年，診斷領域將成為核酸分離純化市場中最大的應用領域。”
核酸分離純化市場可按應用領域細分為診斷、藥物發現與研發、個人化醫療、農業和動物研究以及其他應用。 2024年，診斷領域成為市場成長的主要驅動力，這主要是因為DNA/RNA萃取是大多數PCR/NAAT檢測的關鍵第一步。此外，基於定序的臨床檢測數量的不斷成長也推動了市場擴張。感染疾病檢測、呼吸道檢測和腫瘤分子檢測等常規檢測量龐大，維持了市場穩定的需求。診斷檢查室也優先採用標準化和檢驗的工作流程，以減少檢測結果的變異性，避免重複檢測，並縮短檢測結果的報告時間。
“預計從2025年到2030年，亞太地區核酸分離純化市場將以最高的複合年成長率成長。”
亞太地區預計將成為市場成長最快的區域。這一成長主要得益於人群基因組學計畫的擴展以及對精準醫療日益成長的關注。此外，該地區對罕見疾病和遺傳疾病的診斷和監測需求不斷成長，尤其是在日本和中國等老齡化社會。因此，定序和其他分子檢測技術在常規醫療保健中的應用越來越廣泛。
本報告涵蓋的公司簡介清單：
- 賽默飛世爾科技公司（美國）
- 默克集團（德國）
- 凱傑（德國）
- F. Hoffmann-La Roche Ltd.（瑞士）
- Promega公司（美國）
- 安捷倫科技公司（美國）
- 丹納赫（美國）
- Bio-Rad Laboratories, Inc.（美國）
- Illumina公司（美國）
- Takara Bio Inc.（日本）
- 新英格蘭生物實驗室（美國）
- Abcam Plc（英國）
- KILPEST印度有限公司（印度）
- Apical Scientific Sdn. Bhd.（馬來西亞）
- Endress+Hauser Group Services AG（瑞士）
- GENAXXON生物科學有限公司（德國）
- LGC生物搜尋技術公司（美國）
- Zymo 研究島（美國）
- Norgen Biotek Corp.（加拿大）
- Omega Bio-Tek公司（美國）
- 福爾根生物科技有限公司（中國）
- 天根生物科技（北京）（中國）
- AutoGen公司（美國）
- PCR Biosystems（英國）
- Biogenuix（印度）
調查範圍
本研究報告從產品類型、方法、應用、最終用戶和地區等維度分析了核酸萃取和純化市場。報告涵蓋了影響核酸分離和純化市場成長的關鍵因素（促進因素、挑戰、機會、限制因素等）的詳細資訊。該報告對主要產業參與企業進行了深入分析，包括其業務概況、產品系列、新產品發布、合作關係、夥伴關係、協議和其他關鍵策略，以及與核酸分離和純化市場相關的最新發展動態。此外，報告還對核酸分離和純化市場生態系統中的主要參與者和新興新創公司進行了競爭分析。
購買本報告的主要好處
本報告對核酸分離純化市場及其細分市場的整體銷售額進行了最精準的估算，旨在幫助市場領導和新參與企業。報告也有助於相關人員深入了解競爭格局，合理定位自身業務，並制定有效的打入市場策略。此外，報告還為相關人員提供了市場趨勢、關鍵促進因素和挑戰的見解。
本報告深入分析了以下幾點：
對影響市場成長的因素進行分析，包括關鍵促進因素（醫療和研究領域常規 PCR/qPCR 和 NGS 檢測的擴展，以及更多國家公共衛生基因組監測的擴展）、阻礙因素（高成本和高容量檢測所需時間）、機遇（自動化影響通量、可追溯性和人員配備柔軟性，cfDNA、腫瘤學和用於低投入工作流程的高級 NAIP 產品流程的高級 NAIP 產品（由於工作流程的高級更新）
- 產品開發與創新：核酸萃取純化市場新上市產品的詳細分析
- 市場發展：盈利市場的全面資訊－本報告分析了各個地區的市場。
- 市場多元化：全面介紹核酸分離純化市場的新產品、未開發的市場、近期趨勢和投資狀況。
- 競爭對手分析：賽默飛世爾科技公司（美國）、默克集團（德國）、凱傑公司（德國）、羅氏公司（瑞士）、普羅米加公司（美國）、安捷倫科技公司（美國）、丹納赫公司（美國）、博雷德實驗室公司（美國）、伊魯米加公司（英國）、寶美生物公司（美國生物公司（美國） Sdn. Bhd.（馬來西亞）、恩德斯豪斯集團服務股份公司（瑞士）、GENAXXON bioscience GmbH（德國）及LGC Biosearch Technologies（美國）等。
目錄
第1章：引言
第2章執行摘要
第3章重要考察
第4章 市場概覽
- 市場動態
- 促進因素
- 抑制因子
- 機會
- 任務
- 未滿足的需求和未開發的領域
- 相互關聯的市場與跨產業機遇
- 一級/二級/三級公司的策略性舉措
第5章 產業趨勢
- 波特五力分析
- 宏觀經濟展望
- 價值鏈分析
- 供應鏈分析
- 生態系分析
- 價格分析
- 重要會議和活動
- 影響我們客戶公司業務的趨勢/變化
- 投資及資金籌措活動
- 案例研究分析
- 2025年美國關稅對核酸萃取與純化市場的影響
第6章：技術進步、人工智慧的影響、專利、創新與未來應用
- 技術分析
- 技術/產品藍圖
- 專利分析
- 未來應用
- 人工智慧/通用人工智慧對核酸萃取和純化市場的影響
- 成功案例和實際應用
第7章永續性和監管情勢
- 監理情勢
- 對永續性和監管政策舉措的影響
- 認證、標籤檢視和環境標準
第8章：顧客趨勢與購買行為
- 決策流程
- 買方相關人員和採購評估標準
- 實施障礙和內部挑戰
- 各個終端用戶產業尚未滿足的需求
- 市場盈利
第9章 核酸萃取和純化市場（按產品分類）
- 成套工具
- 試劑
- 裝置
第10章 核酸萃取和純化市場（依方法分類）
- 利用磁珠進行萃取純化
- 利用試劑進行萃取純化
- 基於柱的萃取和純化
- 其他
第11章：核酸萃取和純化市場（按類型分類）
- 質體DNA的萃取與純化
- 總RNA萃取與純化
- 基因組DNA的萃取與純化
- 傳訊RNA的萃取與純化
- 循環核酸的萃取與純化
- 微型RNA萃取與純化
- 其他
第12章：核酸萃取和純化市場（按樣品類型分類）
- 細胞樣本
- 保存的組織樣本
- 自免樣品
- 其他
第13章 核酸萃取與純化市場（依應用領域分類）
- 診斷
- 藥物發現與開發
- 個人化醫療
- 農業/動物研究
- 其他
第14章：核酸萃取與純化市場（依最終用戶分類）
- 醫院和診斷中心
- 學術研究機構與政府研究機構
- 製藥和生物技術公司
- 受託研究機構
- 其他
第15章 核酸萃取與純化市場（依地區分）
- 北美洲
- 美國
- 加拿大
- 歐洲
- 德國
- 英國
- 法國
- 義大利
- 西班牙
- 其他
- 亞太地區
- 中國
- 日本
- 印度
- 澳洲
- 韓國
- 其他
- 拉丁美洲
- 巴西
- 墨西哥
- 其他
- 中東
- 海灣合作理事會國家
- 其他
- 非洲
第16章 競爭格局
- 主要公司採取的策略/優勢
- 2021-2025年收入分析
- 2025年市佔率分析
- 企業估值矩陣：主要公司，2025 年
- 公司估值矩陣：新創企業/中小企業，2025 年
- 企業估值和財務指標
- 品牌/產品對比
- 競爭格局
第17章：公司簡介
- 大公司
- THERMO FISHER SCIENTIFIC INC.
- QIAGEN NV
- MERCK KGAA
- F. HOFFMANN-LA ROCHE LTD.
- DANAHER CORPORATION
- PROMEGA CORPORATION
- AGILENT TECHNOLOGIES, INC.
- BIO-RAD LABORATORIES, INC.
- ILLUMINA, INC.
- TAKARA BIO INC.
- NEW ENGLAND BIOLABS
- A&A BIOTECHNOLOGY
- REVVITY INC.
- BIONEER CORPORATION
- HIMEDIA LABORATORIES PRIVATE LIMITED
- 其他公司
- KILPEST INDIA LIMITED
- APICAL SCIENTIFIC SDN. BHD.
- ENDRESS+HAUSER GROUP SERVICES AG
- GENAXXON BIOSCIENCE GMBH
- LGC BIOSEARCH TECHNOLOGIES
- ZYMO RESEARCH CORPORATION
- NORGEN BIOTEK CORP.
- OMEGA BIO-TEK, INC.
- FAVORGEN BIOTECH CORPORATION
- TIANGEN BIOTECH（BEIJING）CO., LTD.
- AUTOGEN INC.
- PCR BIOSYSTEMS
- BIOGENUIX
- MP BIOMEDICALS
- NANJING VAZYME BIOTECH CO., LTD.
第18章：調查方法
第19章附錄
Product Code: BT 2398
The nucleic acid isolation and purification market is expected to grow from USD 7.10 billion in 2025 to USD 10.99 billion in 2030, at a CAGR of 9.1% during the forecast period.
| Scope of the Report | |
|---|---|
| Years Considered for the Study | 2024-2030 |
| Base Year | 2024 |
| Forecast Period | 2025-2030 |
| Units Considered | Value (USD billion) |
| Segments | Product, Method, Type, Application, End User, and Region |
| Regions covered | North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa |
PCR and other NAAT workflows are routine in many infectious disease programs. Labs are expanding test menus and handling higher sample volumes. NGS is also moving deeper into clinical use cases, increasing the need for clean DNA/RNA as a first step. Declining extraction quality affects downstream sensitivity. This encourages end users to continue investing in reliable NAIP workflows and reagents.
"The magnetic-bead based isolation and purification segment accounted for the largest share, by method, in the nucleic acid isolation and purification market in 2024."
The nucleic acid isolation and purification market is segmented into magnetic bead-based isolation and purification, column-based isolation and purification, reagent-based isolation and purification, and other methods. In 2024, the magnetic bead-based isolation and purification method dominated the market. This dominance is driven by the compatibility of bead workflows with automation and high-throughput processing, which are priorities for hospitals, reference labs, and large research centers. Bead-based methods also deliver consistent yields and reproducibility across batches, helping labs reduce reruns and maintain turnaround times.
"The diagnostics segment was the largest application segment in the nucleic acid isolation and purification market in 2024."
The nucleic acid isolation and purification market is segmented by application into diagnostics, drug discovery & development, personalized medicine, agriculture & animal research, and other applications. The diagnostics segment led the market in 2024. The primary reason is that DNA/RNA extraction is a necessary first step for most PCR/NAAT assays. In addition, a growing number of sequencing-based clinical tests is supporting expansion. High routine volumes from infectious disease panels, respiratory testing, and oncology molecular assays maintain steady demand. Diagnostic labs also prioritize standardized and validated workflows to reduce variability, avoid reruns, and shorten turnaround times.
"The Asia Pacific region will grow at the highest CAGR in the nucleic acid isolation and purification market from 2025 to 2030."
The Asia Pacific region is estimated to be the fastest-growing segment of the market. This growth is supported by the expansion of population genomics programs and the rising focus on precision medicine. The region is also seeing increased demand for diagnosis and monitoring of rare and genetic diseases, especially in aging populations in markets such as Japan and China. As a result, sequencing and other molecular testing are being adopted more widely in routine healthcare.
The primary interviews conducted for this report can be categorized as follows:
- By Company Type: Tier 1- 40%, Tier 2- 30% and Tier 3- 30%
- By Designation: Directors- 20%, Managers- 10% and Others - 70%,
- By Region: North America -35%, Europe -25%, Asia Pacific -25%, Latin America -10%, and Middle East -5%.
List of Companies Profiled in the Report:
- Thermo Fisher Scientific Inc. (US)
- Merck KGaA (Germany)
- QIAGEN (Germany)
- F. Hoffmann-La Roche Ltd. (Switzerland)
- Promega Corporation (US)
- Agilent Technologies, Inc. (US)
- Danaher(US)
- Bio-Rad Laboratories, Inc. (US)
- Illumina, Inc. (US)
- Takara Bio Inc. (Japan)
- New England Biolabs (US)
- Abcam Plc (UK)
- KILPEST India Limited (India)
- Apical Scientific Sdn. Bhd. (Malaysia)
- Endress+Hauser Group Services AG (Switzerland)
- GENAXXON bioscience GmbH (Germany)
- LGC Biosearch Technologies (US)
- Zymo Research Corporation (US)
- Norgen Biotek Corp. (Canada)
- Omega Bio-Tek, Inc. (US)
- FAVORGEN Biotech Corp. (China)
- TIANGEN Biotech (Beijing) Co., Ltd. (China)
- AutoGen Inc. (US)
- PCR Biosystems (UK)
- Biogenuix (India)
Research Coverage
This research report categorizes the nucleic acid isolation and purification market by product [Kits, Reagents, Instruments (Manual, Automatic)], by type (Plasmid DNA isolation and purification, Total RNA isolation and purification, Genomic DNA isolation and purification, Messenger RNA isolation and purification, Circulating nucleic acid isolation and purification, MicroRNA isolation and purification, Other types), by method (Magnetic bead-based isolation and purification, Reagent-based isolation and purification, Column-based isolation and purification, Other methods), by application (Diagnostics, Drug discovery & development, Personalized medicine, Agriculture and animal research, Other applications), by end user (Hospitals and diagnostic centers, Academic and government research institutes, Pharmaceutical and biotechnology companies, Contract Research Organizations (CROs), Other end users), and by region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa). The scope of the report covers detailed information on the major factors, such as drivers, challenges, opportunities, and restraints, that influence the growth of the nucleic acid isolation and purification market. A detailed analysis of key industry players has been conducted to provide insights into their business overview, product portfolio, key strategies such as product launches, collaborations, partnerships, expansions, agreements, and recent developments associated with the nucleic acid isolation and purification market. Competitive analysis of top players and upcoming startups in the nucleic acid isolation and purification market ecosystem is also covered in this report.
Key Benefits of Buying the Report
The report will help market leaders and new entrants by providing the closest approximations of revenue for the overall nucleic acid isolation and purification market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain insights to better position their business and develop suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide information on the key market drivers, restraints, opportunities, and challenges.
The report provides insights into the following points:
Analysis of key drivers (routine PCR/qPCR and NGS testing scaling across care and research, expanding public health genomic surveillance in more countries), restraints (high cost and time required for high-volume testing), opportunities (automation impacting throughput, traceability, and staffing resilience, premium NAIP products for cfDNA, oncology, and low-input workflows), and challenges (variability due to PCR inhibitors and matrix effects) influencing the growth of the market.
- Product Development/Innovation: Detailed insights on newly launched products of the nucleic acid isolation and purification market
- Market Development: Comprehensive information about lucrative markets - the report analyzes the market across varied regions.
- Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the nucleic acid isolation and purification market
- Competitive Assessment: Thermo Fisher Scientific Inc. (US), Merck KGaA (Germany), QIAGEN (Germany), F. Hoffmann-La Roche Ltd. (Switzerland), Promega Corporation (US), Agilent Technologies, Inc. (US), Danaher(US), Bio-Rad Laboratories, Inc. (US), Illumina, Inc. (US), Takara Bio Inc. (Japan), New England Biolabs (US), Abcam Plc (UK), KILPEST India Limited (India), Apical Scientific Sdn. Bhd. (Malaysia), Endress+Hauser Group Services AG (Switzerland), GENAXXON bioscience GmbH (Germany), and LGC Biosearch Technologies (US), among others
TABLE OF CONTENTS
1 INTRODUCTION
- 1.1 STUDY OBJECTIVES
- 1.2 MARKET DEFINITION
- 1.3 STUDY SCOPE
- 1.3.1 MARKET SEGMENTATION & REGIONAL SCOPE
- 1.4 INCLUSIONS & EXCLUSIONS
- 1.4.1 YEARS CONSIDERED
- 1.4.2 CURRENCY CONSIDERED
- 1.5 STAKEHOLDERS
- 1.6 SUMMARY OF CHANGES
2 EXECUTIVE SUMMARY
- 2.1 MARKET HIGHLIGHTS & KEY INSIGHTS
- 2.2 KEY MARKET PARTICIPANTS: MAPPING OF STRATEGIC DEVELOPMENTS
- 2.3 DISRUPTIVE TRENDS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET
- 2.4 HIGH-GROWTH SEGMENTS
- 2.5 REGIONAL SNAPSHOT: MARKET SIZE, GROWTH RATE, AND FORECAST
3 PREMIUM INSIGHTS
- 3.1 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET OVERVIEW
- 3.2 NORTH AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT
- 3.3 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
- 3.4 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET SHARE, BY END USER, 2026 VS 2031 (%)
4 MARKET OVERVIEW
- 4.1 INTRODUCTION
- 4.2 MARKET DYNAMICS
- 4.2.1 DRIVERS
- 4.2.1.1 Rising adoption of automated nucleic acid extraction systems
- 4.2.1.2 Increasing need for high-purity and inhibitor-free nucleic acid recovery
- 4.2.1.3 Broadening use of magnetic bead-based purification chemistries
- 4.2.1.4 Growth in complex and difficult sample-type processing
- 4.2.2 RESTRAINTS
- 4.2.2.1 Price pressure and partial commoditization of routine extraction kits
- 4.2.2.2 Continued use of manual and low-cost in-house methods in small & mid-sized labs
- 4.2.2.3 Workflow substitution in selected use cases
- 4.2.3 OPPORTUNITIES
- 4.2.3.1 Premium extraction solutions for low-input and cell-free nucleic acids
- 4.2.3.2 Expansion of automated benchtop and mid-throughput extraction platforms
- 4.2.3.3 Workflow integration with quantitation, tracking, and digital reporting
- 4.2.3.4 Application-specific extraction workflows in biopharma and CGT
- 4.2.4 CHALLENGES
- 4.2.4.1 Pre-analytical variability that affects extraction output
- 4.2.4.2 Removal of inhibitors and contaminants from difficult matrices
- 4.2.4.3 Standardization and validation for regulated or sensitive workflows
- 4.2.1 DRIVERS
- 4.3 UNMET NEEDS & WHITE SPACES
- 4.4 INTERCONNECTED MARKETS & CROSS-SECTOR OPPORTUNITIES
- 4.5 STRATEGIC MOVES BY TIER-1/2/3 PLAYERS
5 INDUSTRY TRENDS
- 5.1 PORTER'S FIVE FORCES ANALYSIS
- 5.1.1 THREAT OF NEW ENTRANTS
- 5.1.2 THREAT OF SUBSTITUTES
- 5.1.3 BARGAINING POWER OF BUYERS
- 5.1.4 BARGAINING POWER OF SUPPLIERS
- 5.1.5 INTENSITY OF COMPETITIVE RIVALRY
- 5.2 MACROECONOMIC OUTLOOK
- 5.2.1 INTRODUCTION
- 5.2.2 GDP TRENDS & FORECAST
- 5.2.3 TRENDS IN GLOBAL NUCLEIC ACID ISOLATION AND PURIFICATION MARKET
- 5.2.4 TRENDS IN HEALTHCARE EXPENDITURE
- 5.3 VALUE CHAIN ANALYSIS
- 5.4 SUPPLY CHAIN ANALYSIS
- 5.5 ECOSYSTEM ANALYSIS
- 5.5.1 EMERGING BUSINESS MODELS & ECOSYSTEM SHIFTS
- 5.6 PRICING ANALYSIS
- 5.6.1 INDICATIVE SELLING PRICE OF KEY PLAYERS, BY PRODUCT, 2025
- 5.6.2 INDICATIVE SELLING PRICE OF NAIP PRODUCTS, BY REGION, 2025
- 5.7 KEY CONFERENCES & EVENTS
- 5.8 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
- 5.9 INVESTMENT/FUNDING ACTIVITY
- 5.10 CASE STUDY ANALYSIS
- 5.11 IMPACT OF 2025 US TARIFFS ON NUCLEIC ACID ISOLATION AND PURIFICATION MARKET
- 5.11.1 INTRODUCTION
- 5.11.2 KEY TARIFF RATES
- 5.11.3 PRICE IMPACT ANALYSIS
- 5.11.4 IMPACT ON COUNTRY/REGION
- 5.11.4.1 US
- 5.11.4.2 Europe
- 5.11.4.3 Asia Pacific
- 5.11.5 IMPACT ON END-USE INDUSTRIES
- 5.11.5.1 Hospitals & diagnostic centers
- 5.11.5.2 Academic & government research institutes
- 5.11.5.3 Pharmaceutical & biotechnology companies
- 5.11.5.4 Contract research organizations (CROs)
- 5.11.5.5 Other end users
6 TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS
- 6.1 TECHNOLOGY ANALYSIS
- 6.1.1 KEY TECHNOLOGIES
- 6.1.1.1 Silica membrane/spin column purification
- 6.1.1.2 Magnetic bead-based purification
- 6.1.1.3 Reagent-based extraction/organic extraction
- 6.1.2 COMPLEMENTARY TECHNOLOGIES
- 6.1.2.1 Sample lysis & homogenization technologies
- 6.1.2.2 Centrifugation & vacuum manifold systems
- 6.1.3 ADJACENT TECHNOLOGIES
- 6.1.3.1 PCR & qPCR technologies
- 6.1.1 KEY TECHNOLOGIES
- 6.2 TECHNOLOGY/PRODUCT ROADMAP
- 6.3 PATENT ANALYSIS
- 6.3.1 TOP APPLICANTS/OWNERS (COMPANIES) FOR NUCLEIC ACID ISOLATION AND PURIFICATION PRODUCT/TECHNOLOGY PATENTS, 2015-2025
- 6.4 FUTURE APPLICATIONS
- 6.5 IMPACT OF AI/GEN AI ON NUCLEIC ACID ISOLATION AND PURIFICATION MARKET
- 6.5.1 TOP USE CASES & MARKET POTENTIAL
- 6.5.2 CASE STUDIES OF AI IMPLEMENTATION IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET
- 6.5.3 INTERCONNECTED ADJACENT ECOSYSTEMS & IMPACT ON MARKET PLAYERS
- 6.5.4 CLIENTS' READINESS TO ADOPT GENERATIVE AI IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET
- 6.6 SUCCESS STORIES & REAL-WORLD APPLICATIONS
7 SUSTAINABILITY & REGULATORY LANDSCAPE
- 7.1 REGULATORY LANDSCAPE
- 7.1.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
- 7.1.2 REGULATORY FRAMEWORK/KEY REGULATIONS
- 7.1.2.1 North America
- 7.1.2.1.1 US
- 7.1.2.1.2 Canada
- 7.1.2.2 Europe
- 7.1.2.2.1 Germany
- 7.1.2.2.2 France
- 7.1.2.2.3 UK
- 7.1.2.3 Asia Pacific
- 7.1.2.3.1 Japan
- 7.1.2.3.2 China
- 7.1.2.3.3 India
- 7.1.2.3.4 South Korea
- 7.1.2.4 Latin America
- 7.1.2.4.1 Brazil
- 7.1.2.5 Middle East
- 7.1.2.5.1 Saudi Arabia
- 7.1.2.1 North America
- 7.1.3 INDUSTRY STANDARDS
- 7.2 SUSTAINABILITY IMPACT & REGULATORY POLICY INITIATIVES
- 7.3 CERTIFICATIONS, LABELING, AND ECO-STANDARDS
8 CUSTOMER LANDSCAPE & BUYER BEHAVIOR
- 8.1 DECISION-MAKING PROCESS
- 8.2 BUYER STAKEHOLDERS & BUYING EVALUATION CRITERIA
- 8.2.1 KEY STAKEHOLDERS IN BUYING PROCESS
- 8.2.2 KEY BUYING CRITERIA, BY END USER
- 8.3 ADOPTION BARRIERS & INTERNAL CHALLENGES
- 8.4 UNMET NEEDS FROM VARIOUS END-USE INDUSTRIES
- 8.5 MARKET PROFITABILITY
9 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT
- 9.1 INTRODUCTION
- 9.2 KITS
- 9.2.1 KITS TO ACCOUNT FOR LARGEST SHARE OF MARKET DURING FORECAST PERIOD
- 9.3 REAGENTS
- 9.3.1 AVAILABILITY OF READY-TO-USE REAGENTS TO DRIVE GROWTH
- 9.4 INSTRUMENTS
- 9.4.1 AUTOMATIC INSTRUMENTS
- 9.4.1.1 Benefits of automatic instruments to drive growth
- 9.4.2 MANUAL INSTRUMENTS
- 9.4.2.1 Growing demand for nucleic acid isolation and purification in research and clinical applications to drive growth
- 9.4.1 AUTOMATIC INSTRUMENTS
10 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD
- 10.1 INTRODUCTION
- 10.2 MAGNETIC BEAD-BASED ISOLATION AND PURIFICATION
- 10.2.1 MAGNETIC BEAD-BASED ISOLATION AND PURIFICATION SEGMENT TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD
- 10.3 REAGENT-BASED ISOLATION AND PURIFICATION
- 10.3.1 REAGENT-BASED ISOLATION AND PURIFICATION SEGMENT TO REGISTER STEADY GROWTH DURING FORECAST PERIOD
- 10.4 COLUMN-BASED ISOLATION AND PURIFICATION
- 10.4.1 GROWING POPULARITY OF COLUMN-BASED ISOLATION AND PURIFICATION IN CURRENT KITS TO BOOST MARKET
- 10.5 OTHER ISOLATION AND PURIFICATION METHODS
11 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE
- 11.1 INTRODUCTION
- 11.2 PLASMID DNA ISOLATION AND PURIFICATION
- 11.2.1 PLASMID DNA ISOLATION AND PURIFICATION TO ACCOUNT FOR LARGEST SHARE OF MARKET
- 11.3 TOTAL RNA ISOLATION AND PURIFICATION
- 11.3.1 WIDE USE OF TOTAL RNA ISOLATION AND PURIFICATION FOR RESEARCH AND DIAGNOSTIC APPLICATIONS TO BOOST MARKET
- 11.4 GENOMIC DNA ISOLATION AND PURIFICATION
- 11.4.1 IMPORTANCE OF GENOMIC DNA ISOLATION IN GENETIC-BASED TESTS TO SUPPORT GROWTH
- 11.5 MESSENGER RNA ISOLATION AND PURIFICATION
- 11.5.1 ROLE PLAYED BY MESSENGER RNA ISOLATION AND PURIFICATION IN GENE EXPRESSION AND TRANSCRIPTOMICS TO DRIVE GROWTH
- 11.6 CIRCULATING NUCLEIC ACID ISOLATION AND PURIFICATION
- 11.6.1 ABILITY OF CIRCULATING NAIP TO ENABLE COLLECTION OF GENETIC INFORMATION FROM BODY FLUIDS TO BOOST ADOPTION
- 11.7 MICRORNA ISOLATION AND PURIFICATION
- 11.7.1 GROWING APPLICATIONS OF MICRORNA ISOLATION AND PURIFICATION IN DRUG DEVELOPMENT RESEARCH TO FUEL GROWTH
- 11.8 OTHER NUCLEIC ACID ISOLATION AND PURIFICATION TYPES
12 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY SAMPLE TYPE
- 12.1 INTRODUCTION
- 12.2 CELLULAR SAMPLES
- 12.2.1 WBCS
- 12.2.1.1 Strong demand from routine blood-based genomics and diagnostic testing workflows to boost market
- 12.2.2 CULTURED CELLS
- 12.2.2.1 Core segment supporting drug discovery, cell biology, and biopharma R&D applications
- 12.2.3 BACTERIAL
- 12.2.3.1 Rising adoption in infectious disease, microbiome, and environmental testing workflows to fuel market growth
- 12.2.4 OTHER CELLULAR SAMPLES
- 12.2.1 WBCS
- 12.3 PRESERVED TISSUE SAMPLES
- 12.3.1 FRESH/FROZEN TISSUES
- 12.3.1.1 Preferred for high-quality nucleic acid recovery in research and translational studies
- 12.3.2 FFPE (FORMALIN-FIXED PARAFFIN-EMBEDDED)
- 12.3.2.1 Fastest-growing segment fueled by increasing use of archived clinical samples in oncology
- 12.3.3 OTHER PRESERVED TISSUE SAMPLES
- 12.3.1 FRESH/FROZEN TISSUES
- 12.4 CELL-FREE SAMPLES
- 12.4.1 CFDNA/CTDNA
- 12.4.1.1 Key growth driver enabling liquid biopsy and real-time disease monitoring
- 12.4.2 OTHER CELL-FREE SAMPLES
- 12.4.1 CFDNA/CTDNA
- 12.5 OTHER SAMPLES
13 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION
- 13.1 INTRODUCTION
- 13.2 DIAGNOSTICS
- 13.2.1 DIAGNOSTIC APPLICATIONS TO DOMINATE MARKET DURING FORECAST PERIOD
- 13.3 DRUG DISCOVERY & DEVELOPMENT
- 13.3.1 POTENTIAL OF NAIP TO HELP IN DEVELOPMENT OF DRUGS FOR RARE DISEASES TO BOOST MARKET
- 13.4 PERSONALIZED MEDICINE
- 13.4.1 RISING INCIDENCE OF CANCER AND INCREASING RESEARCH AND FUNDING TO DRIVE GROWTH
- 13.5 AGRICULTURE & ANIMAL RESEARCH
- 13.5.1 FAVORABLE FUNDING SCENARIO TO SUPPORT MARKET GROWTH
- 13.6 OTHER APPLICATIONS
14 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER
- 14.1 INTRODUCTION
- 14.2 HOSPITALS & DIAGNOSTIC CENTERS
- 14.2.1 RISING FOCUS ON PERSONALIZED MEDICINE IN HOSPITALS TO DRIVE MARKET GROWTH
- 14.3 ACADEMIC & GOVERNMENT RESEARCH INSTITUTES
- 14.3.1 INCREASE IN RESEARCH INTENSITY TO DRIVE USAGE OF NUCLEIC ACID ISOLATION AND PURIFICATION SYSTEMS
- 14.4 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
- 14.4.1 INCREASING NUMBER OF RESEARCH PROJECTS IN GENOMICS AND RELATED AREAS TO DRIVE SEGMENT GROWTH
- 14.5 CONTRACT RESEARCH ORGANIZATIONS
- 14.5.1 CONTRACT RESEARCH ORGANIZATIONS TO REGISTER STEADY GROWTH DURING FORECAST PERIOD
- 14.6 OTHER END USERS
15 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION
- 15.1 INTRODUCTION
- 15.2 NORTH AMERICA
- 15.2.1 US
- 15.2.1.1 Government and private funding to support market growth
- 15.2.2 CANADA
- 15.2.2.1 Growing investments in genomics to boost market demand
- 15.2.1 US
- 15.3 EUROPE
- 15.3.1 GERMANY
- 15.3.1.1 Germany to dominate market in Europe
- 15.3.2 UK
- 15.3.2.1 Government support for research through investments, funds, and grants to support market growth
- 15.3.3 FRANCE
- 15.3.3.1 Increasing number of established biotech facilities to drive market growth
- 15.3.4 ITALY
- 15.3.4.1 Government support to drive market growth in Italy
- 15.3.5 SPAIN
- 15.3.5.1 High adoption of advanced diagnostic technologies to drive market growth in Spain
- 15.3.6 REST OF EUROPE
- 15.3.1 GERMANY
- 15.4 ASIA PACIFIC
- 15.4.1 CHINA
- 15.4.1.1 Strong domestic genomics scale and tightening IVD framework to drive NAIP adoption
- 15.4.2 JAPAN
- 15.4.2.1 Whole-genome medicine and structured clinical implementation to support premium NAIP demand
- 15.4.3 INDIA
- 15.4.3.1 National genomics initiatives and rising domestic manufacturing to expand NAIP opportunities
- 15.4.4 AUSTRALIA
- 15.4.4.1 Precision health funding and rare-disease genomics to support advanced NAIP workflows
- 15.4.5 SOUTH KOREA
- 15.4.5.1 Support from governments to drive market in region
- 15.4.6 REST OF ASIA PACIFIC (ROAPAC)
- 15.4.1 CHINA
- 15.5 LATIN AMERICA
- 15.5.1 BRAZIL
- 15.5.1.1 Brazil to dominate LATAM market
- 15.5.2 MEXICO
- 15.5.2.1 Favorable trade agreements to support imports and improve access to NAIP instruments in Mexico
- 15.5.3 REST OF LATIN AMERICA
- 15.5.1 BRAZIL
- 15.6 MIDDLE EAST
- 15.6.1 GCC COUNTRIES
- 15.6.1.1 Saudi Arabia
- 15.6.1.1.1 National genomics strategy and precision medicine expansion to accelerate NAIP demand
- 15.6.1.2 UAE
- 15.6.1.2.1 Molecular lab standardization and genomics-led healthcare investment to strengthen NAIP adoption
- 15.6.1.3 Rest of GCC Countries
- 15.6.1.1 Saudi Arabia
- 15.6.2 REST OF MIDDLE EAST
- 15.6.1 GCC COUNTRIES
- 15.7 AFRICA
- 15.7.1 GOVERNMENT SUPPORT FOR RESEARCH STUDIES TO FUEL GROWTH
16 COMPETITIVE LANDSCAPE
- 16.1 INTRODUCTION
- 16.2 STRATEGIES ADOPTED BY KEY PLAYERS/RIGHT TO WIN
- 16.3 REVENUE ANALYSIS, 2021-2025
- 16.4 MARKET SHARE ANALYSIS, 2025
- 16.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025
- 16.5.1 STARS
- 16.5.2 EMERGING LEADERS
- 16.5.3 PERVASIVE PLAYERS
- 16.5.4 PARTICIPANTS
- 16.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2025
- 16.5.5.1 Company footprint
- 16.5.5.2 Region footprint
- 16.5.5.3 Product footprint
- 16.5.5.4 Method footprint
- 16.5.5.5 Application footprint
- 16.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2025
- 16.6.1 PROGRESSIVE COMPANIES
- 16.6.2 RESPONSIVE COMPANIES
- 16.6.3 DYNAMIC COMPANIES
- 16.6.4 STARTING BLOCKS
- 16.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2025
- 16.6.5.1 List of key startups/SMEs
- 16.6.5.2 Competitive benchmarking of key startups/SMEs
- 16.7 COMPANY VALUATION & FINANCIAL METRICS
- 16.7.1 FINANCIAL METRICS
- 16.7.2 COMPANY VALUATION
- 16.8 BRAND/PRODUCT COMPARISON
- 16.8.1 BRAND/PRODUCT COMPARATIVE ANALYSIS, BY PRODUCT
- 16.9 COMPETITIVE SCENARIO
- 16.9.1 PRODUCT LAUNCHES
- 16.9.2 DEALS
17 COMPANY PROFILES
- 17.1 KEY PLAYERS
- 17.1.1 THERMO FISHER SCIENTIFIC INC.
- 17.1.1.1 Business overview
- 17.1.1.2 Products offered
- 17.1.1.3 Recent developments
- 17.1.1.3.1 Product launches
- 17.1.1.3.2 Expansions
- 17.1.1.3.3 Other developments
- 17.1.1.4 MnM view
- 17.1.1.4.1 Key strengths
- 17.1.1.4.2 Strategic choices
- 17.1.1.4.3 Weaknesses & competitive threats
- 17.1.2 QIAGEN N.V.
- 17.1.2.1 Business overview
- 17.1.2.2 Products offered
- 17.1.2.3 Recent developments
- 17.1.2.3.1 Product launches
- 17.1.2.3.2 Deals
- 17.1.2.4 MnM view
- 17.1.2.4.1 Key strengths
- 17.1.2.4.2 Strategic choices
- 17.1.2.4.3 Weaknesses & competitive threats
- 17.1.3 MERCK KGAA
- 17.1.3.1 Business overview
- 17.1.3.2 Products offered
- 17.1.3.3 Recent developments
- 17.1.3.3.1 Product launches
- 17.1.3.4 MnM view
- 17.1.3.4.1 Key strengths
- 17.1.3.4.2 Strategic choices
- 17.1.3.4.3 Weaknesses & competitive threats
- 17.1.4 F. HOFFMANN-LA ROCHE LTD.
- 17.1.4.1 Business overview
- 17.1.4.2 Products offered
- 17.1.4.3 Recent developments
- 17.1.4.3.1 Other developments
- 17.1.4.4 MnM view
- 17.1.4.4.1 Key strengths
- 17.1.4.4.2 Strategic choices
- 17.1.4.4.3 Weaknesses & competitive threats
- 17.1.5 DANAHER CORPORATION
- 17.1.5.1 Business overview
- 17.1.5.2 Products offered
- 17.1.5.3 Recent developments
- 17.1.5.3.1 Deals
- 17.1.5.4 MnM view
- 17.1.5.4.1 Key strengths
- 17.1.5.4.2 Strategic choices
- 17.1.5.4.3 Weaknesses & competitive threats
- 17.1.6 PROMEGA CORPORATION
- 17.1.6.1 Business overview
- 17.1.6.2 Products offered
- 17.1.6.3 Recent developments
- 17.1.6.3.1 Deals
- 17.1.7 AGILENT TECHNOLOGIES, INC.
- 17.1.7.1 Business overview
- 17.1.7.2 Products offered
- 17.1.7.3 Recent developments
- 17.1.7.3.1 Other Developments
- 17.1.8 BIO-RAD LABORATORIES, INC.
- 17.1.8.1 Business overview
- 17.1.8.2 Products offered
- 17.1.9 ILLUMINA, INC.
- 17.1.9.1 Business overview
- 17.1.9.2 Products offered
- 17.1.9.3 Recent developments
- 17.1.9.3.1 Product launches
- 17.1.10 TAKARA BIO INC.
- 17.1.10.1 Business overview
- 17.1.10.2 Products offered
- 17.1.11 NEW ENGLAND BIOLABS
- 17.1.11.1 Business overview
- 17.1.11.2 Products offered
- 17.1.11.3 Recent developments
- 17.1.11.3.1 Product launches
- 17.1.12 A&A BIOTECHNOLOGY
- 17.1.12.1 Business overview
- 17.1.12.2 Products offered
- 17.1.13 REVVITY INC.
- 17.1.13.1 Business overview
- 17.1.13.2 Products offered
- 17.1.14 BIONEER CORPORATION
- 17.1.14.1 Business overview
- 17.1.14.2 Products offered
- 17.1.15 HIMEDIA LABORATORIES PRIVATE LIMITED
- 17.1.15.1 Business overview
- 17.1.15.2 Products offered
- 17.1.1 THERMO FISHER SCIENTIFIC INC.
- 17.2 OTHER PLAYERS
- 17.2.1 KILPEST INDIA LIMITED
- 17.2.2 APICAL SCIENTIFIC SDN. BHD.
- 17.2.3 ENDRESS+HAUSER GROUP SERVICES AG
- 17.2.4 GENAXXON BIOSCIENCE GMBH
- 17.2.5 LGC BIOSEARCH TECHNOLOGIES
- 17.2.6 ZYMO RESEARCH CORPORATION
- 17.2.7 NORGEN BIOTEK CORP.
- 17.2.8 OMEGA BIO-TEK, INC.
- 17.2.9 FAVORGEN BIOTECH CORPORATION
- 17.2.10 TIANGEN BIOTECH(BEIJING)CO., LTD.
- 17.2.11 AUTOGEN INC.
- 17.2.12 PCR BIOSYSTEMS
- 17.2.13 BIOGENUIX
- 17.2.14 MP BIOMEDICALS
- 17.2.15 NANJING VAZYME BIOTECH CO., LTD.
18 RESEARCH METHODOLOGY
- 18.1 RESEARCH DATA
- 18.1.1 SECONDARY DATA
- 18.1.1.1 Key data from secondary sources
- 18.1.2 PRIMARY DATA
- 18.1.2.1 Key data from primary sources
- 18.1.2.2 Key primary participants
- 18.1.2.3 Breakdown of primary interviews
- 18.1.2.4 Key industry insights
- 18.1.1 SECONDARY DATA
- 18.2 MARKET SIZE ESTIMATION
- 18.2.1 SEGMENTAL MARKET SIZE ESTIMATION
- 18.3 MARKET GROWTH RATE PROJECTIONS
- 18.4 FACTOR ANALYSIS
- 18.5 DATA TRIANGULATION
- 18.6 RESEARCH ASSUMPTIONS
- 18.7 RESEARCH LIMITATIONS & RISK ASSESSMENT
- 18.8 SRISK ASSESSMENT
19 APPENDIX
- 19.1 DISCUSSION GUIDE
- 19.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
- 19.3 CUSTOMIZATION OPTIONS
- 19.4 RELATED REPORTS
- 19.5 AUTHOR DETAILS
List of Tables
- TABLE 1 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: IMPACT ANALYSIS
- TABLE 2 NEXT-GENERATION SEQUENCING MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 3 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: PORTER'S FIVE FORCES ANALYSIS
- TABLE 4 HEALTH EXPENDITURE AND FINANCING, 2015-2024 (IN PERCENTAGE OF GDP)
- TABLE 5 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: ROLE IN ECOSYSTEM
- TABLE 6 INDICATIVE SELLING PRICE OF KEY PLAYERS, BY PRODUCT, 2025
- TABLE 7 INDICATIVE SELLING PRICE OF NAIP PRODUCTS, BY REGION, 2025
- TABLE 8 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: KEY CONFERENCES & EVENTS, 2026-2027
- TABLE 9 CASE STUDY 1: DNA EXTRACTION FROM ARCHEOLOGICAL AND RECENT SKELETAL REMAINS
- TABLE 10 CASE STUDY 2: CLINICAL LAB AUTOMATION FOR ROUTINE MOLECULAR SAMPLE PREPARATION
- TABLE 11 CASE STUDY 3: AUTOMATED EXTRACTION OF FFPE SAMPLES FOR ONCOLOGY/NGS WORKFLOWS
- TABLE 12 US-ADJUSTED RECIPROCAL TARIFF RATES
- TABLE 13 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: KEY COMPANIES' TECHNOLOGY/PRODUCT ROADMAP
- TABLE 14 DETAILED ANALYSIS OF KEY PATENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET
- TABLE 15 CASE STUDIES OF AI IMPLEMENTATION IN NUCLEIC ACID ISOLATION AND PURIFICATION
- TABLE 16 CLIENTS' READINESS TO ADOPT GENERATIVE AI IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET
- TABLE 17 KEY SUCCESS STORIES WITH RESPECT TO REAL-WORLD APPLICATION IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET
- TABLE 18 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
- TABLE 19 US FDA: MEDICAL DEVICE CLASSIFICATION
- TABLE 20 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
- TABLE 21 EUROPE: CLASSIFICATION OF DEVICES
- TABLE 22 JAPAN: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS
- TABLE 23 CHINA: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS
- TABLE 24 SOUTH KOREA: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS
- TABLE 25 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY PRODUCT (%)
- TABLE 26 KEY BUYING CRITERIA, BY END USER
- TABLE 27 UNMET NEED ACROSS DIFFERENT END USERS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET
- TABLE 28 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
- TABLE 29 NUCLEIC ACID ISOLATION AND PURIFICATION KITS MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 30 NORTH AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION KITS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 31 EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION KITS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 32 ASIA PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION KITS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 33 LATIN AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION KITS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 34 MIDDLE EAST: NUCLEIC ACID ISOLATION AND PURIFICATION KITS MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 35 GCC COUNTRIES: NUCLEIC ACID ISOLATION AND PURIFICATION KITS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 36 NUCLEIC ACID ISOLATION AND PURIFICATION REAGENTS MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 37 NORTH AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION REAGENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 38 EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION REAGENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 39 ASIA PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION REAGENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 40 LATIN AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION REAGENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 41 MIDDLE EAST: NUCLEIC ACID ISOLATION AND PURIFICATION REAGENTS MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 42 GCC COUNTRIES: NUCLEIC ACID ISOLATION AND PURIFICATION REAGENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 43 NUCLEIC ACID ISOLATION AND PURIFICATION INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 44 NUCLEIC ACID ISOLATION AND PURIFICATION INSTRUMENTS MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 45 NORTH AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION INSTRUMENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 46 EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION INSTRUMENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 47 ASIA PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION INSTRUMENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 48 LATIN AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION INSTRUMENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 49 MIDDLE EAST: NUCLEIC ACID ISOLATION AND PURIFICATION INSTRUMENTS MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 50 GCC COUNTRIES: NUCLEIC ACID ISOLATION AND PURIFICATION INSTRUMENTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 51 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR AUTOMATIC INSTRUMENTS, BY REGION, 2024-2031 (USD MILLION)
- TABLE 52 NORTH AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR AUTOMATIC INSTRUMENTS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 53 EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR AUTOMATIC INSTRUMENTS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 54 ASIA PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR AUTOMATIC INSTRUMENTS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 55 LATIN AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR AUTOMATIC INSTRUMENTS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 56 MIDDLE EAST: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR AUTOMATIC INSTRUMENTS, BY REGION, 2024-2031 (USD MILLION)
- TABLE 57 GCC COUNTRIES: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR AUTOMATIC INSTRUMENTS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 58 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR MANUAL INSTRUMENTS, BY REGION, 2024-2031 (USD MILLION)
- TABLE 59 NORTH AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR MANUAL INSTRUMENTS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 60 EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR MANUAL INSTRUMENTS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 61 ASIA PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR MANUAL INSTRUMENTS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 62 LATIN AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR MANUAL INSTRUMENTS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 63 MIDDLE EAST: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR MANUAL INSTRUMENTS, BY REGION, 2024-2031 (USD MILLION)
- TABLE 64 GCC COUNTRIES: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR MANUAL INSTRUMENTS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 65 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2024-2031 (USD MILLION)
- TABLE 66 MAGNETIC BEAD-BASED ISOLATION AND PURIFICATION MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 67 NORTH AMERICA: MAGNETIC BEAD-BASED ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 68 EUROPE: MAGNETIC BEAD-BASED ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 69 ASIA PACIFIC: MAGNETIC BEAD-BASED ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 70 LATIN AMERICA: MAGNETIC BEAD-BASED ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 71 MIDDLE EAST: MAGNETIC BEAD-BASED ISOLATION AND PURIFICATION MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 72 GCC COUNTRIES: MAGNETIC BEAD-BASED ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 73 REAGENT-BASED ISOLATION AND PURIFICATION MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 74 NORTH AMERICA: REAGENT-BASED ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 75 EUROPE: REAGENT-BASED ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 76 ASIA PACIFIC: REAGENT-BASED ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 77 LATIN AMERICA: REAGENT-BASED ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 78 MIDDLE EAST: REAGENT-BASED ISOLATION AND PURIFICATION MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 79 GCC COUNTRIES: REAGENT-BASED ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 80 COLUMN-BASED ISOLATION AND PURIFICATION MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 81 NORTH AMERICA: COLUMN-BASED ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 82 EUROPE: COLUMN-BASED ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 83 ASIA PACIFIC: COLUMN-BASED ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 84 LATIN AMERICA: COLUMN-BASED ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 85 MIDDLE EAST: COLUMN-BASED ISOLATION AND PURIFICATION MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 86 GCC COUNTRIES: COLUMN-BASED ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 87 OTHER ISOLATION AND PURIFICATION METHODS MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 88 NORTH AMERICA: OTHER ISOLATION AND PURIFICATION METHODS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 89 EUROPE: OTHER ISOLATION AND PURIFICATION METHODS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 90 ASIA PACIFIC: OTHER ISOLATION AND PURIFICATION METHODS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 91 LATIN AMERICA: OTHER ISOLATION AND PURIFICATION METHODS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 92 MIDDLE EAST: OTHER ISOLATION AND PURIFICATION METHODS MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 93 GCC COUNTRIES: OTHER ISOLATION AND PURIFICATION METHODS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 94 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 95 PLASMID DNA ISOLATION AND PURIFICATION MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 96 NORTH AMERICA: PLASMID DNA ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 97 EUROPE: PLASMID DNA ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 98 ASIA PACIFIC: PLASMID DNA ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 99 LATIN AMERICA: PLASMID DNA ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 100 MIDDLE EAST: PLASMID DNA ISOLATION AND PURIFICATION MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 101 GCC COUNTRIES: PLASMID DNA ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 102 TOTAL RNA ISOLATION AND PURIFICATION MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 103 NORTH AMERICA: TOTAL RNA ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 104 EUROPE: TOTAL RNA ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 105 ASIA PACIFIC: TOTAL RNA ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 106 LATIN AMERICA: TOTAL RNA ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 107 MIDDLE EAST: TOTAL RNA ISOLATION AND PURIFICATION MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 108 GCC COUNTRIES: TOTAL RNA ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 109 GENOMIC DNA ISOLATION AND PURIFICATION MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 110 NORTH AMERICA: GENOMIC DNA ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 111 EUROPE: GENOMIC DNA ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 112 ASIA PACIFIC: GENOMIC DNA ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 113 LATIN AMERICA: GENOMIC DNA ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 114 MIDDLE EAST: GENOMIC DNA ISOLATION AND PURIFICATION MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 115 GCC COUNTRIES: GENOMIC DNA ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 116 MESSENGER RNA ISOLATION AND PURIFICATION MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 117 NORTH AMERICA: MESSENGER RNA ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 118 EUROPE: MESSENGER RNA ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 119 ASIA PACIFIC: MESSENGER RNA ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 120 LATIN AMERICA: MESSENGER RNA ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 121 MIDDLE EAST: MESSENGER RNA ISOLATION AND PURIFICATION MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 122 GCC COUNTRIES: MESSENGER RNA ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 123 CIRCULATING NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 124 NORTH AMERICA: CIRCULATING NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 125 EUROPE: CIRCULATING NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 126 ASIA PACIFIC: CIRCULATING NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 127 LATIN AMERICA: CIRCULATING NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 128 MIDDLE EAST: CIRCULATING NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 129 GCC COUNTRIES: CIRCULATING NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 130 MICRORNA ISOLATION AND PURIFICATION MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 131 NORTH AMERICA: MICRORNA ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 132 EUROPE: MICRORNA ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 133 ASIA PACIFIC: MICRORNA ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 134 LATIN AMERICA: MICRORNA ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 135 MIDDLE EAST: MICRORNA ISOLATION AND PURIFICATION MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 136 GCC COUNTRIES: MICRORNA ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 137 OTHER NUCLEIC ACID ISOLATION AND PURIFICATION TYPES MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 138 NORTH AMERICA: OTHER NUCLEIC ACID ISOLATION AND PURIFICATION TYPES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 139 EUROPE: OTHER NUCLEIC ACID ISOLATION AND PURIFICATION TYPES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 140 ASIA PACIFIC: OTHER NUCLEIC ACID ISOLATION AND PURIFICATION TYPES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 141 LATIN AMERICA: OTHER NUCLEIC ACID ISOLATION AND PURIFICATION TYPES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 142 MIDDLE EAST: OTHER NUCLEIC ACID ISOLATION AND PURIFICATION TYPES MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 143 GCC COUNTRIES: OTHER NUCLEIC ACID ISOLATION AND PURIFICATION TYPES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 144 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY SAMPLE TYPE, 2024-2031 (USD MILLION)
- TABLE 145 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR CELLULAR SAMPLES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 146 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR CELLULAR SAMPLES, BY REGION, 2024-2031 (USD MILLION)
- TABLE 147 NORTH AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR CELLULAR SAMPLES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 148 EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR CELLULAR SAMPLES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 149 ASIA PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR CELLULAR SAMPLES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 150 LATIN AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR CELLULAR SAMPLES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 151 MIDDLE EAST: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR CELLULAR SAMPLES, BY REGION, 2024-2031 (USD MILLION)
- TABLE 152 GCC COUNTRIES: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR CELLULAR SAMPLES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 153 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR WBCS, BY REGION, 2024-2031 (USD MILLION)
- TABLE 154 NORTH AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR WBCS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 155 EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR WBCS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 156 ASIA PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR WBCS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 157 LATIN AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR WBCS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 158 MIDDLE EAST: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR WBCS, BY REGION, 2024-2031 (USD MILLION)
- TABLE 159 GCC COUNTRIES: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR WBCS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 160 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR CULTURED CELLS, BY REGION, 2024-2031 (USD MILLION)
- TABLE 161 NORTH AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR CULTURED CELLS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 162 EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR CULTURED CELLS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 163 ASIA PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR CULTURED CELLS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 164 LATIN AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR CULTURED CELLS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 165 MIDDLE EAST: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR CULTURED CELLS, BY REGION, 2024-2031 (USD MILLION)
- TABLE 166 GCC COUNTRIES: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR CULTURED CELLS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 167 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR BACTERIAL CELLS, BY REGION, 2024-2031 (USD MILLION)
- TABLE 168 NORTH AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR BACTERIAL CELLS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 169 EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR BACTERIAL CELLS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 170 ASIA PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR BACTERIAL CELLS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 171 LATIN AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR BACTERIAL CELLS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 172 MIDDLE EAST: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR BACTERIAL CELLS, BY REGION, 2024-2031 (USD MILLION)
- TABLE 173 GCC COUNTRIES: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR BACTERIAL CELLS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 174 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR OTHER CELLULAR SAMPLES, BY REGION, 2024-2031 (USD MILLION)
- TABLE 175 NORTH AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR OTHER CELLULAR SAMPLES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 176 EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR OTHER CELLULAR SAMPLES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 177 ASIA PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR OTHER CELLULAR SAMPLES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 178 LATIN AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR OTHER CELLULAR SAMPLES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 179 MIDDLE EAST: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR OTHER CELLULAR SAMPLES, BY REGION, 2024-2031 (USD MILLION)
- TABLE 180 GCC COUNTRIES: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR OTHER CELLULAR SAMPLES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 181 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR PRESERVED TISSUE SAMPLES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 182 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR PRESERVED TISSUE SAMPLES, BY REGION, 2024-2031 (USD MILLION)
- TABLE 183 NORTH AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR PRESERVED TISSUE SAMPLES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 184 EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR PRESERVED TISSUE SAMPLES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 185 ASIA PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR PRESERVED TISSUE SAMPLES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 186 LATIN AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR PRESERVED TISSUE SAMPLES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 187 MIDDLE EAST: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR PRESERVED TISSUE SAMPLES, BY REGION, 2024-2031 (USD MILLION)
- TABLE 188 GCC COUNTRIES: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR PRESERVED TISSUE SAMPLES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 189 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR FRESH/FROZEN TISSUES, BY REGION, 2024-2031 (USD MILLION)
- TABLE 190 NORTH AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR FRESH/FROZEN TISSUES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 191 EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR FRESH/FROZEN TISSUES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 192 ASIA PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR FRESH/FROZEN TISSUES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 193 LATIN AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR FRESH/FROZEN TISSUES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 194 MIDDLE EAST: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR FRESH/FROZEN TISSUES, BY REGION, 2024-2031 (USD MILLION)
- TABLE 195 GCC COUNTRIES: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR FRESH/FROZEN TISSUES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 196 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR FFPE, BY REGION, 2024-2031 (USD MILLION)
- TABLE 197 NORTH AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR FFPE, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 198 EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR FFPE, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 199 ASIA PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR FFPE, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 200 LATIN AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR FFPE, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 201 MIDDLE EAST: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR FFPE, BY REGION, 2024-2031 (USD MILLION)
- TABLE 202 GCC COUNTRIES: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR FFPE, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 203 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR OTHER PRESERVED TISSUE SAMPLES, BY REGION, 2024-2031 (USD MILLION)
- TABLE 204 NORTH AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR OTHER PRESERVED TISSUE SAMPLES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 205 EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR OTHER PRESERVED TISSUE SAMPLES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 206 ASIA PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR OTHER PRESERVED TISSUE SAMPLES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 207 LATIN AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR OTHER PRESERVED TISSUE SAMPLES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 208 MIDDLE EAST: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR OTHER PRESERVED TISSUE SAMPLES, BY REGION, 2024-2031 (USD MILLION)
- TABLE 209 GCC COUNTRIES: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR OTHER PRESERVED TISSUE SAMPLES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 210 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR CELL-FREE SAMPLES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 211 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR CELL-FREE SAMPLES, BY REGION, 2024-2031 (USD MILLION)
- TABLE 212 NORTH AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR CELL-FREE SAMPLES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 213 EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR CELL-FREE SAMPLES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 214 ASIA PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR CELL-FREE SAMPLES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 215 LATIN AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR CELL-FREE SAMPLES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 216 MIDDLE EAST: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR CELL-FREE SAMPLES, BY REGION, 2024-2031 (USD MILLION)
- TABLE 217 GCC COUNTRIES: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR CELL-FREE SAMPLES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 218 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR CFDNA/CTDNA, BY REGION, 2024-2031 (USD MILLION)
- TABLE 219 NORTH AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR CFDNA/CTDNA, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 220 EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR CFDNA/CTDNA, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 221 ASIA PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR CFDNA/CTDNA, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 222 LATIN AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR CFDNA/CTDNA, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 223 MIDDLE EAST: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR CFDNA/CTDNA, BY REGION, 2024-2031 (USD MILLION)
- TABLE 224 GCC COUNTRIES: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR CFDNA/CTDNA, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 225 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR OTHER CELL-FREE SAMPLES, BY REGION, 2024-2031 (USD MILLION)
- TABLE 226 NORTH AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR OTHER CELL-FREE SAMPLES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 227 EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR OTHER CELL-FREE SAMPLES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 228 ASIA PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR OTHER CELL-FREE SAMPLES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 229 LATIN AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR OTHER CELL-FREE SAMPLES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 230 MIDDLE EAST: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR OTHER CELL-FREE SAMPLES, BY REGION, 2024-2031 (USD MILLION)
- TABLE 231 GCC COUNTRIES: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR OTHER CELL-FREE SAMPLES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 232 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR OTHER SAMPLES, BY REGION, 2024-2031 (USD MILLION)
- TABLE 233 NORTH AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR OTHER SAMPLES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 234 EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR OTHER SAMPLES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 235 ASIA PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR OTHER SAMPLES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 236 LATIN AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR OTHER SAMPLES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 237 MIDDLE EAST: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR OTHER SAMPLES, BY REGION, 2024-2031 (USD MILLION)
- TABLE 238 GCC COUNTRIES: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR OTHER SAMPLES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 239 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
- TABLE 240 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR DIAGNOSTIC APPLICATIONS, BY REGION, 2024-2031 (USD MILLION)
- TABLE 241 NORTH AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 242 EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 243 ASIA PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 244 LATIN AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 245 MIDDLE EAST: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR DIAGNOSTIC APPLICATIONS, BY REGION, 2024-2031 (USD MILLION)
- TABLE 246 GCC COUNTRIES: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 247 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY REGION, 2024-2031 (USD MILLION)
- TABLE 248 NORTH AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 249 EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 250 ASIA PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 251 LATIN AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 252 MIDDLE EAST: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY REGION, 2024-2031 (USD MILLION)
- TABLE 253 GCC COUNTRIES: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 254 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR PERSONALIZED MEDICINE APPLICATIONS, BY REGION, 2024-2031 (USD MILLION)
- TABLE 255 NORTH AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR PERSONALIZED MEDICINE APPLICATIONS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 256 EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR PERSONALIZED MEDICINE APPLICATIONS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 257 ASIA PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR PERSONALIZED MEDICINE APPLICATIONS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 258 LATIN AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR PERSONALIZED MEDICINE APPLICATIONS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 259 MIDDLE EAST: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR PERSONALIZED MEDICINE APPLICATIONS, BY REGION, 2024-2031 (USD MILLION)
- TABLE 260 GCC COUNTRIES: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR PERSONALIZED MEDICINE APPLICATIONS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 261 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR AGRICULTURE & ANIMAL RESEARCH APPLICATIONS, BY REGION, 2024-2031 (USD MILLION)
- TABLE 262 NORTH AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR AGRICULTURE & ANIMAL RESEARCH APPLICATIONS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 263 EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR AGRICULTURE & ANIMAL RESEARCH APPLICATIONS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 264 ASIA PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR AGRICULTURE & ANIMAL RESEARCH APPLICATIONS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 265 LATIN AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR AGRICULTURE & ANIMAL RESEARCH APPLICATIONS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 266 MIDDLE EAST: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR AGRICULTURE & ANIMAL RESEARCH APPLICATIONS, BY REGION, 2024-2031 (USD MILLION)
- TABLE 267 GCC COUNTRIES: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR AGRICULTURE & ANIMAL RESEARCH APPLICATIONS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 268 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR OTHER APPLICATIONS, BY REGION, 2024-2031 (USD MILLION)
- TABLE 269 NORTH AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 270 EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 271 ASIA PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 272 LATIN AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 273 MIDDLE EAST: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR OTHER APPLICATIONS, BY REGION, 2024-2031 (USD MILLION)
- TABLE 274 GCC COUNTRIES: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 275 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 276 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR HOSPITALS & DIAGNOSTIC CENTERS, BY REGION, 2024-2031 (USD MILLION)
- TABLE 277 NORTH AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR HOSPITALS & DIAGNOSTIC CENTERS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 278 EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR HOSPITALS & DIAGNOSTIC CENTERS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 279 ASIA PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR HOSPITALS & DIAGNOSTIC CENTERS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 280 LATIN AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR HOSPITALS & DIAGNOSTIC CENTERS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 281 MIDDLE EAST: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR HOSPITALS & DIAGNOSTIC CENTERS, BY REGION, 2024-2031 (USD MILLION)
- TABLE 282 GCC COUNTRIES: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR HOSPITALS & DIAGNOSTIC CENTERS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 283 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR ACADEMIC & GOVERNMENT RESEARCH INSTITUTES, BY REGION, 2024-2031 (USD MILLION)
- TABLE 284 NORTH AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR ACADEMIC & GOVERNMENT RESEARCH INSTITUTES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 285 EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR ACADEMIC & GOVERNMENT RESEARCH INSTITUTES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 286 ASIA PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR ACADEMIC & GOVERNMENT RESEARCH INSTITUTES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 287 LATIN AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR ACADEMIC & GOVERNMENT RESEARCH INSTITUTES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 288 MIDDLE EAST: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR ACADEMIC & GOVERNMENT RESEARCH INSTITUTES, BY REGION, 2024-2031 (USD MILLION)
- TABLE 289 GCC COUNTRIES: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR ACADEMIC & GOVERNMENT RESEARCH INSTITUTES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 290 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2024-2031 (USD MILLION)
- TABLE 291 NORTH AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 292 EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 293 ASIA PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 294 LATIN AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 295 MIDDLE EAST: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2024-2031 (USD MILLION)
- TABLE 296 GCC COUNTRIES: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 297 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2024-2031 (USD MILLION)
- TABLE 298 NORTH AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 299 EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 300 ASIA PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 301 LATIN AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 302 MIDDLE EAST: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2024-2031 (USD MILLION)
- TABLE 303 GCC COUNTRIES: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 304 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR OTHER END USERS, BY REGION, 2024-2031 (USD MILLION)
- TABLE 305 NORTH AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR OTHER END USERS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 306 EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR OTHER END USERS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 307 ASIA PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR OTHER END USERS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 308 LATIN AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR OTHER END USERS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 309 MIDDLE EAST: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR OTHER END USERS, BY REGION, 2024-2031 (USD MILLION)
- TABLE 310 GCC COUNTRIES: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR OTHER END USERS, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 311 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 312 NORTH AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 313 NORTH AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
- TABLE 314 NORTH AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 315 NORTH AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2024-2031 (USD MILLION)
- TABLE 316 NORTH AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 317 NORTH AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY SAMPLE TYPE, 2024-2031 (USD MILLION)
- TABLE 318 NORTH AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR CELLULAR SAMPLES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 319 NORTH AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR PRESERVED TISSUE SAMPLES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 320 NORTH AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR CELL-FREE SAMPLES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 321 NORTH AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
- TABLE 322 NORTH AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 323 US: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
- TABLE 324 US: NUCLEIC ACID ISOLATION AND PURIFICATION INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 325 US: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2024-2031 (USD MILLION)
- TABLE 326 US: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 327 US: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY SAMPLE TYPE, 2024-2031 (USD MILLION)
- TABLE 328 US: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR CELLULAR SAMPLES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 329 US: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR PRESERVED TISSUE SAMPLES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 330 US: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR CELL-FREE SAMPLES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 331 US: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
- TABLE 332 US: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 333 CANADA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
- TABLE 334 CANADA: NUCLEIC ACID ISOLATION AND PURIFICATION INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 335 CANADA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2024-2031 (USD MILLION)
- TABLE 336 CANADA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 337 CANADA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY SAMPLE TYPE, 2024-2031 (USD MILLION)
- TABLE 338 CANADA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR CELLULAR SAMPLES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 339 CANADA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR PRESERVED TISSUE SAMPLES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 340 CANADA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR CELL-FREE SAMPLES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 341 CANADA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
- TABLE 342 CANADA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 343 EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 344 EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
- TABLE 345 EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 346 EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2024-2031 (USD MILLION)
- TABLE 347 EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 348 EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY SAMPLE TYPE, 2024-2031 (USD MILLION)
- TABLE 349 EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR CELLULAR SAMPLES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 350 EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR PRESERVED TISSUE SAMPLES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 351 EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR CELL-FREE SAMPLES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 352 EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
- TABLE 353 EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 354 GERMANY: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
- TABLE 355 GERMANY: NUCLEIC ACID ISOLATION AND PURIFICATION INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 356 GERMANY: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2024-2031 (USD MILLION)
- TABLE 357 GERMANY: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 358 GERMANY: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY SAMPLE TYPE, 2024-2031 (USD MILLION)
- TABLE 359 GERMANY: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR CELLULAR SAMPLES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 360 GERMANY: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR PRESERVED TISSUE SAMPLES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 361 GERMANY: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR CELL-FREE SAMPLES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 362 GERMANY: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
- TABLE 363 GERMANY: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 364 UK: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
- TABLE 365 UK: NUCLEIC ACID ISOLATION AND PURIFICATION INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 366 UK: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2024-2031 (USD MILLION)
- TABLE 367 UK: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 368 UK: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY SAMPLE TYPE, 2024-2031 (USD MILLION)
- TABLE 369 UK: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR CELLULAR SAMPLES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 370 UK: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR PRESERVED TISSUE SAMPLES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 371 UK: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR CELL-FREE SAMPLES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 372 UK: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
- TABLE 373 UK: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 374 FRANCE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
- TABLE 375 FRANCE: NUCLEIC ACID ISOLATION AND PURIFICATION INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 376 FRANCE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2024-2031 (USD MILLION)
- TABLE 377 FRANCE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 378 FRANCE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY SAMPLE TYPE, 2024-2031 (USD MILLION)
- TABLE 379 FRANCE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR CELLULAR SAMPLES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 380 FRANCE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR PRESERVED TISSUE SAMPLES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 381 FRANCE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR CELL-FREE SAMPLES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 382 FRANCE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
- TABLE 383 FRANCE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 384 ITALY: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
- TABLE 385 ITALY: NUCLEIC ACID ISOLATION AND PURIFICATION INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 386 ITALY: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2024-2031 (USD MILLION)
- TABLE 387 ITALY: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 388 ITALY: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY SAMPLE TYPE, 2024-2031 (USD MILLION)
- TABLE 389 ITALY: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR CELLULAR SAMPLES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 390 ITALY: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR PRESERVED TISSUE SAMPLES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 391 ITALY: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR CELL-FREE SAMPLES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 392 ITALY: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
- TABLE 393 ITALY: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 394 SPAIN: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
- TABLE 395 SPAIN: NUCLEIC ACID ISOLATION AND PURIFICATION INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 396 SPAIN: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2024-2031 (USD MILLION)
- TABLE 397 SPAIN: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 398 SPAIN: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY SAMPLE TYPE, 2024-2031 (USD MILLION)
- TABLE 399 SPAIN: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR CELLULAR SAMPLES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 400 SPAIN: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR PRESERVED TISSUE SAMPLES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 401 SPAIN: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR CELL-FREE SAMPLES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 402 SPAIN: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
- TABLE 403 SPAIN: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 404 REST OF EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
- TABLE 405 REST OF EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 406 REST OF EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2024-2031 (USD MILLION)
- TABLE 407 REST OF EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 408 REST OF EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY SAMPLE TYPE, 2024-2031 (USD MILLION)
- TABLE 409 REST OF EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR CELLULAR SAMPLES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 410 REST OF EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR PRESERVED TISSUE SAMPLES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 411 REST OF EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR CELL-FREE SAMPLES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 412 REST OF EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
- TABLE 413 REST OF EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 414 ASIA PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 415 ASIA PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
- TABLE 416 ASIA PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 417 ASIA PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2024-2031 (USD MILLION)
- TABLE 418 ASIA PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 419 ASIA PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY SAMPLE TYPE, 2024-2031 (USD MILLION)
- TABLE 420 ASIA PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR CELLULAR SAMPLES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 421 ASIA PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR PRESERVED TISSUE SAMPLES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 422 ASIA PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR CELL-FREE SAMPLES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 423 ASIA PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
- TABLE 424 ASIA PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 425 CHINA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
- TABLE 426 CHINA: NUCLEIC ACID ISOLATION AND PURIFICATION INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 427 CHINA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2024-2031 (USD MILLION)
- TABLE 428 CHINA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 429 CHINA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY SAMPLE TYPE, 2024-2031 (USD MILLION)
- TABLE 430 CHINA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR CELLULAR SAMPLES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 431 CHINA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR PRESERVED TISSUE SAMPLES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 432 CHINA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR CELL-FREE SAMPLES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 433 CHINA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
- TABLE 434 CHINA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 435 JAPAN: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
- TABLE 436 JAPAN: NUCLEIC ACID ISOLATION AND PURIFICATION INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 437 JAPAN: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2024-2031 (USD MILLION)
- TABLE 438 JAPAN: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 439 JAPAN: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY SAMPLE TYPE, 2024-2031 (USD MILLION)
- TABLE 440 JAPAN: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR CELLULAR SAMPLES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 441 JAPAN: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR PRESERVED TISSUE SAMPLES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 442 JAPAN: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR CELL-FREE SAMPLES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 443 JAPAN: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
- TABLE 444 JAPAN: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 445 INDIA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
- TABLE 446 INDIA: NUCLEIC ACID ISOLATION AND PURIFICATION INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 447 INDIA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2024-2031 (USD MILLION)
- TABLE 448 INDIA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 449 INDIA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY SAMPLE TYPE, 2024-2031 (USD MILLION)
- TABLE 450 INDIA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR CELLULAR SAMPLES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 451 INDIA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR PRESERVED TISSUE SAMPLES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 452 INDIA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR CELL-FREE SAMPLES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 453 INDIA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
- TABLE 454 INDIA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 455 AUSTRALIA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
- TABLE 456 AUSTRALIA: NUCLEIC ACID ISOLATION AND PURIFICATION INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 457 AUSTRALIA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2024-2031 (USD MILLION)
- TABLE 458 AUSTRALIA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 459 AUSTRALIA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY SAMPLE TYPE, 2024-2031 (USD MILLION)
- TABLE 460 AUSTRALIA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR CELLULAR SAMPLES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 461 AUSTRALIA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR PRESERVED TISSUE SAMPLES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 462 AUSTRALIA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR CELL-FREE SAMPLES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 463 AUSTRALIA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
- TABLE 464 AUSTRALIA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 465 SOUTH KOREA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
- TABLE 466 SOUTH KOREA: NUCLEIC ACID ISOLATION AND PURIFICATION INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 467 SOUTH KOREA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2024-2031 (USD MILLION)
- TABLE 468 SOUTH KOREA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 469 SOUTH KOREA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY SAMPLE TYPE, 2024-2031 (USD MILLION)
- TABLE 470 SOUTH KOREA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR CELLULAR SAMPLES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 471 SOUTH KOREA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR PRESERVED TISSUE SAMPLES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 472 SOUTH KOREA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR CELL-FREE SAMPLES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 473 SOUTH KOREA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
- TABLE 474 SOUTH KOREA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 475 REST OF ASIA PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
- TABLE 476 REST OF ASIA PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 477 REST OF ASIA PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2024-2031 (USD MILLION)
- TABLE 478 REST OF ASIA PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 479 REST OF ASIA PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY SAMPLE TYPE, 2024-2031 (USD MILLION)
- TABLE 480 REST OF ASIA PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR CELLULAR SAMPLES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 481 REST OF ASIA PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR PRESERVED TISSUE SAMPLES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 482 REST OF ASIA PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR CELL-FREE SAMPLES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 483 REST OF ASIA PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
- TABLE 484 REST OF ASIA PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 485 LATIN AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 486 LATIN AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
- TABLE 487 LATIN AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 488 LATIN AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2024-2031 (USD MILLION)
- TABLE 489 LATIN AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 490 LATIN AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY SAMPLE TYPE, 2024-2031 (USD MILLION)
- TABLE 491 LATIN AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR CELLULAR SAMPLES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 492 LATIN AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR PRESERVED TISSUE SAMPLES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 493 LATIN AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR CELL-FREE SAMPLES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 494 LATIN AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
- TABLE 495 LATIN AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 496 BRAZIL: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
- TABLE 497 BRAZIL: NUCLEIC ACID ISOLATION AND PURIFICATION INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 498 BRAZIL: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2024-2031 (USD MILLION)
- TABLE 499 BRAZIL: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 500 BRAZIL: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY SAMPLE TYPE, 2024-2031 (USD MILLION)
- TABLE 501 BRAZIL: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR CELLULAR SAMPLES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 502 BRAZIL: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR PRESERVED TISSUE SAMPLES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 503 BRAZIL: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR CELL-FREE SAMPLES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 504 BRAZIL: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
- TABLE 505 BRAZIL: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 506 MEXICO: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
- TABLE 507 MEXICO: NUCLEIC ACID ISOLATION AND PURIFICATION INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 508 MEXICO: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2024-2031 (USD MILLION)
- TABLE 509 MEXICO: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 510 MEXICO: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY SAMPLE TYPE, 2024-2031 (USD MILLION)
- TABLE 511 MEXICO: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR CELLULAR SAMPLES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 512 MEXICO: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR PRESERVED TISSUE SAMPLES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 513 MEXICO: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR CELL-FREE SAMPLES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 514 MEXICO: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
- TABLE 515 MEXICO: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 516 REST OF LATIN AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
- TABLE 517 REST OF LATIN AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 518 REST OF LATIN AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2024-2031 (USD MILLION)
- TABLE 519 REST OF LATIN AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 520 REST OF LATIN AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY SAMPLE TYPE, 2024-2031 (USD MILLION)
- TABLE 521 REST OF LATIN AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR CELLULAR SAMPLES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 522 REST OF LATIN AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR PRESERVED TISSUE SAMPLES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 523 REST OF LATIN AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR CELL-FREE SAMPLES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 524 REST OF LATIN AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
- TABLE 525 REST OF LATIN AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 526 MIDDLE EAST: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION, 2024-2031 (USD MILLION)
- TABLE 527 MIDDLE EAST: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
- TABLE 528 MIDDLE EAST: NUCLEIC ACID ISOLATION AND PURIFICATION INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 529 MIDDLE EAST: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2024-2031 (USD MILLION)
- TABLE 530 MIDDLE EAST: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 531 MIDDLE EAST: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY SAMPLE TYPE, 2024-2031 (USD MILLION)
- TABLE 532 MIDDLE EAST: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR CELLULAR SAMPLES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 533 MIDDLE EAST: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR PRESERVED TISSUE SAMPLES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 534 MIDDLE EAST: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR CELL-FREE SAMPLES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 535 MIDDLE EAST: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
- TABLE 536 MIDDLE EAST: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 537 GCC COUNTRIES: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
- TABLE 538 GCC COUNTRIES: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
- TABLE 539 GCC COUNTRIES: NUCLEIC ACID ISOLATION AND PURIFICATION INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 540 GCC COUNTRIES: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2024-2031 (USD MILLION)
- TABLE 541 GCC COUNTRIES: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 542 GCC COUNTRIES: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY SAMPLE TYPE, 2024-2031 (USD MILLION)
- TABLE 543 GCC COUNTRIES: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR CELLULAR SAMPLES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 544 GCC COUNTRIES: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR PRESERVED TISSUE SAMPLES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 545 GCC COUNTRIES: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR CELL-FREE SAMPLES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 546 GCC COUNTRIES: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
- TABLE 547 GCC COUNTRIES: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 548 SAUDI ARABIA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
- TABLE 549 SAUDI ARABIA: NUCLEIC ACID ISOLATION AND PURIFICATION INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 550 SAUDI ARABIA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2024-2031 (USD MILLION)
- TABLE 551 SAUDI ARABIA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 552 SAUDI ARABIA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY SAMPLE TYPE, 2024-2031 (USD MILLION)
- TABLE 553 SAUDI ARABIA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR CELLULAR SAMPLES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 554 SAUDI ARABIA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR PRESERVED TISSUE SAMPLES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 555 SAUDI ARABIA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR CELL-FREE SAMPLES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 556 SAUDI ARABIA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
- TABLE 557 SAUDI ARABIA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 558 UAE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
- TABLE 559 UAE: NUCLEIC ACID ISOLATION AND PURIFICATION INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 560 UAE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2024-2031 (USD MILLION)
- TABLE 561 UAE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 562 UAE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY SAMPLE TYPE, 2024-2031 (USD MILLION)
- TABLE 563 UAE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR CELLULAR SAMPLES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 564 UAE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR PRESERVED TISSUE SAMPLES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 565 UAE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR CELL-FREE SAMPLES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 566 UAE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
- TABLE 567 UAE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 568 REST OF GCC COUNTRIES: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
- TABLE 569 REST OF GCC COUNTRIES: NUCLEIC ACID ISOLATION AND PURIFICATION INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 570 REST OF GCC COUNTRIES: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2024-2031 (USD MILLION)
- TABLE 571 REST OF GCC COUNTRIES: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 572 REST OF GCC COUNTRIES: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY SAMPLE TYPE, 2024-2031 (USD MILLION)
- TABLE 573 REST OF GCC COUNTRIES: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR CELLULAR SAMPLES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 574 REST OF GCC COUNTRIES: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR PRESERVED TISSUE SAMPLES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 575 REST OF GCC COUNTRIES: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR CELL-FREE SAMPLES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 576 REST OF GCC COUNTRIES: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
- TABLE 577 REST OF GCC COUNTRIES: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 578 REST OF MIDDLE EAST: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
- TABLE 579 REST OF MIDDLE EAST: NUCLEIC ACID ISOLATION AND PURIFICATION INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 580 REST OF MIDDLE EAST: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2024-2031 (USD MILLION)
- TABLE 581 REST OF MIDDLE EAST: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 582 REST OF MIDDLE EAST: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY SAMPLE TYPE, 2024-2031 (USD MILLION)
- TABLE 583 REST OF MIDDLE EAST: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR CELLULAR SAMPLES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 584 REST OF MIDDLE EAST: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR PRESERVED TISSUE SAMPLES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 585 REST OF MIDDLE EAST: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR CELL-FREE SAMPLES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 586 REST OF MIDDLE EAST: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
- TABLE 587 REST OF MIDDLE EAST: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 588 AFRICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2024-2031 (USD MILLION)
- TABLE 589 AFRICA: NUCLEIC ACID ISOLATION AND PURIFICATION INSTRUMENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 590 AFRICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2024-2031 (USD MILLION)
- TABLE 591 AFRICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 592 AFRICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY SAMPLE TYPE, 2024-2031 (USD MILLION)
- TABLE 593 AFRICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR CELLULAR SAMPLES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 594 AFRICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR PRESERVED TISSUE SAMPLES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 595 AFRICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR CELL-FREE SAMPLES, BY TYPE, 2024-2031 (USD MILLION)
- TABLE 596 AFRICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
- TABLE 597 AFRICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2024-2031 (USD MILLION)
- TABLE 598 STRATEGIES ADOPTED BY KEY PLAYERS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, 2023-2026
- TABLE 599 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: DEGREE OF COMPETITION
- TABLE 600 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: REGION FOOTPRINT
- TABLE 601 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: PRODUCT FOOTPRINT
- TABLE 602 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: METHOD FOOTPRINT
- TABLE 603 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: APPLICATION FOOTPRINT
- TABLE 604 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: KEY STARTUPS/SMES
- TABLE 605 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES
- TABLE 606 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: PRODUCT LAUNCHES, JANUARY 2023-APRIL 2026
- TABLE 607 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: DEALS, JANUARY 2023- APRIL 2026
- TABLE 608 THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW
- TABLE 609 THERMO FISHER SCIENTIFIC INC.: PRODUCTS OFFERED
- TABLE 610 THERMO FISHER SCIENTIFIC INC.: PRODUCT LAUNCHES, JANUARY 2023-APRIL 2026
- TABLE 611 THERMO FISHER SCIENTIFIC INC.: EXPANSIONS, JANUARY 2023-APRIL 2026
- TABLE 612 THERMO FISHER SCIENTIFIC INC.: OTHER DEVELOPMENTS, JANUARY 2023-APRIL 2026
- TABLE 613 QIAGEN N.V.: COMPANY OVERVIEW
- TABLE 614 QIAGEN N.V.: PRODUCTS OFFERED
- TABLE 615 QIAGEN N.V.: PRODUCT LAUNCHES, JANUARY 2023-APRIL 2026
- TABLE 616 QIAGEN N.V.: DEALS, JANUARY 2023-APRIL 2026
- TABLE 617 MERCK KGAA: COMPANY OVERVIEW
- TABLE 618 MERCK KGAA: PRODUCTS OFFERED
- TABLE 619 MERCK KGAA: PRODUCT LAUNCHES, JANUARY 2023-APRIL 2026
- TABLE 620 F. HOFFMANN-LA ROCHE LTD.: COMPANY OVERVIEW
- TABLE 621 F. HOFFMANN-LA ROCHE LTD.: PRODUCTS OFFERED
- TABLE 622 F. HOFFMANN-LA ROCHE LTD.: OTHER DEVELOPMENTS, JANUARY 2023-APRIL 2026
- TABLE 623 DANAHER CORPORATION: COMPANY OVERVIEW
- TABLE 624 DANAHER CORPORATION: PRODUCTS OFFERED
- TABLE 625 DANAHER CORPORATION: DEALS, JANUARY 2023-APRIL 2026
- TABLE 626 PROMEGA CORPORATION: COMPANY OVERVIEW
- TABLE 627 PROMEGA CORPORATION: PRODUCTS OFFERED
- TABLE 628 PROMEGA CORPORATION: DEALS, JANUARY 2023-APRIL 2026
- TABLE 629 AGILENT TECHNOLOGIES, INC.: COMPANY OVERVIEW
- TABLE 630 AGILENT TECHNOLOGIES, INC.: PRODUCTS OFFERED
- TABLE 631 AGILENT TECHNOLOGIES, INC.: OTHER DEVELOPMENTS, JANUARY 2023-APRIL 2026
- TABLE 632 BIO-RAD LABORATORIES, INC.: COMPANY OVERVIEW
- TABLE 633 BIO-RAD LABORATORIES, INC.: PRODUCTS OFFERED
- TABLE 634 ILLUMINA, INC.: COMPANY OVERVIEW
- TABLE 635 ILLUMINA, INC.: PRODUCTS OFFERED
- TABLE 636 ILLUMINA, INC.: PRODUCT LAUNCHES, JANUARY 2023-APRIL 2026
- TABLE 637 TAKARA BIO INC.: COMPANY OVERVIEW
- TABLE 638 TAKARA BIO INC.: PRODUCTS OFFERED
- TABLE 639 NEW ENGLAND BIOLABS: COMPANY OVERVIEW
- TABLE 640 NEW ENGLAND BIOLABS: PRODUCTS OFFERED
- TABLE 641 NEW ENGLAND BIOLABS: PRODUCT LAUNCHES, JANUARY 2023-MARCH 2026
- TABLE 642 A&A BIOTECHNOLOGY: COMPANY OVERVIEW
- TABLE 643 A&A BIOTECHNOLOGY: PRODUCTS OFFERED
- TABLE 644 REVVITY INC.: COMPANY OVERVIEW
- TABLE 645 REVVITY INC.: PRODUCTS OFFERED
- TABLE 646 BIONEER CORPORATION: COMPANY OVERVIEW
- TABLE 647 BIONEER CORPORATION: PRODUCTS OFFERED
- TABLE 648 HIMEDIA LABORATORIES PRIVATE LIMITED: COMPANY OVERVIEW
- TABLE 649 HIMEDIA LABORATORIES PRIVATE LIMITED: PRODUCTS OFFERED
- TABLE 650 KILPEST INDIA LIMITED: COMPANY OVERVIEW
- TABLE 651 APICAL SCIENTIFIC SDN. BHD.: COMPANY OVERVIEW
- TABLE 652 ENDRESS+HAUSER GROUP SERVICES AG: COMPANY OVERVIEW
- TABLE 653 GENAXXON BIOSCIENCE GMBH: COMPANY OVERVIEW
- TABLE 654 LGC BIOSEARCH TECHNOLOGIES: COMPANY OVERVIEW
- TABLE 655 ZYMO RESEARCH CORPORATION: COMPANY OVERVIEW
- TABLE 656 NORGEN BIOTEK CORP.: COMPANY OVERVIEW
- TABLE 657 OMEGA BIO-TEK, INC.: COMPANY OVERVIEW
- TABLE 658 FAVORGEN BIOTECH CORPORATION: COMPANY OVERVIEW
- TABLE 659 TIANGEN BIOTECH(BEIJING)CO., LTD.: COMPANY OVERVIEW
- TABLE 660 AUTOGEN INC.: COMPANY OVERVIEW
- TABLE 661 PCR BIOSYSTEMS: COMPANY OVERVIEW
- TABLE 662 BIOGENUIX: COMPANY OVERVIEW
- TABLE 663 MP BIOMEDICALS: COMPANY OVERVIEW
- TABLE 664 NANJING VAZYME BIOTECH CO., LTD.: COMPANY OVERVIEW
- TABLE 665 IMPACT ANALYSIS OF SUPPLY-SIDE AND DEMAND-SIDE FACTORS
- TABLE 666 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: RISK ANALYSIS
List of Figures
- FIGURE 1 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET SEGMENTATION & REGIONAL SCOPE
- FIGURE 2 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: YEARS CONSIDERED
- FIGURE 3 MARKET SCENARIO
- FIGURE 4 GLOBAL NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, 2024-2031
- FIGURE 5 MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, 2023-2026
- FIGURE 6 DISRUPTIONS INFLUENCING GROWTH OF NUCLEIC ACID ISOLATION AND PURIFICATION MARKET
- FIGURE 7 HIGH-GROWTH SEGMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, 2026-2031
- FIGURE 8 ASIA PACIFIC TO REGISTER HIGHEST CAGR IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, IN TERMS OF VALUE, DURING FORECAST PERIOD
- FIGURE 9 ADVANCEMENTS IN NUCLEIC ACID ISOLATION AND PURIFICATION PLATFORMS TO DRIVE MARKET GROWTH
- FIGURE 10 KITS ACCOUNTED FOR LARGEST SHARE OF NUCLEIC ACID ISOLATION AND PURIFICATION MARKET IN NORTH AMERICA IN 2025
- FIGURE 11 ASIA PACIFIC IS LIKELY TO BE FASTEST-GROWING MARKET IN GLOBAL NUCLEIC ACID ISOLATION AND PURIFICATION MARKET DURING FORECAST PERIOD
- FIGURE 12 HOSPITALS & DIAGNOSTIC CENTERS TO DOMINATE MARKET DURING FORECAST PERIOD
- FIGURE 13 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
- FIGURE 14 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: PORTER'S FIVE FORCES ANALYSIS
- FIGURE 15 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: VALUE CHAIN ANALYSIS
- FIGURE 16 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: SUPPLY CHAIN ANALYSIS
- FIGURE 17 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: ECOSYSTEM ANALYSIS
- FIGURE 18 INDICATIVE SELLING PRICE OF NAIP PRODUCTS, BY TYPE, 2025
- FIGURE 19 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
- FIGURE 20 VC/PRIVATE EQUITY INVESTMENT TRENDS & STARTUP LANDSCAPE
- FIGURE 21 TOP APPLICANTS/OWNERS (COMPANIES) FOR NUCLEIC ACID ISOLATION AND PURIFICATION PRODUCTS/TECHNOLOGY PATENTS, 2015-2025
- FIGURE 22 IMPACT OF AI/GEN AI ON NUCLEIC ACID ISOLATION AND PURIFICATION MARKET
- FIGURE 23 CANADA: REGULATORY PROCESS FOR MEDICAL DEVICES
- FIGURE 24 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY PRODUCT
- FIGURE 25 KEY BUYING CRITERIA, BY END USER
- FIGURE 26 NORTH AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET SNAPSHOT
- FIGURE 27 ASIA PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET SNAPSHOT
- FIGURE 28 REVENUE ANALYSIS OF KEY PLAYERS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, 2021-2025 (USD MILLION)
- FIGURE 29 MARKET SHARE ANALYSIS OF KEY PLAYERS IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET (2025)
- FIGURE 30 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2025
- FIGURE 31 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: COMPANY FOOTPRINT
- FIGURE 32 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2025
- FIGURE 33 EV/EBITDA OF KEY VENDORS
- FIGURE 34 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
- FIGURE 35 BRAND/PRODUCT COMPARATIVE ANALYSIS, BY PRODUCT
- FIGURE 36 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2025)
- FIGURE 37 QIAGEN N.V.: COMPANY SNAPSHOT (2025)
- FIGURE 38 MERCK KGAA: COMPANY SNAPSHOT (2025)
- FIGURE 39 F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT (2025)
- FIGURE 40 DANAHER CORPORATION: COMPANY SNAPSHOT (2025)
- FIGURE 41 AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2025)
- FIGURE 42 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2025)
- FIGURE 43 ILLUMINA, INC.: COMPANY SNAPSHOT (2025)
- FIGURE 44 TAKARA BIO INC.: COMPANY SNAPSHOT (2025)
- FIGURE 45 REVVITY INC.: COMPANY SNAPSHOT (2025)
- FIGURE 46 BIONEER CORPORATION: COMPANY SNAPSHOT (2025)
- FIGURE 47 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: RESEARCH DESIGN
- FIGURE 48 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: BREAKDOWN OF PRIMARIES
- FIGURE 49 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: INSIGHTS FROM PRIMARIES
- FIGURE 50 GLOBAL NUCLEIC ACID ISOLATION AND PURIFICATION MARKET ESTIMATION (SUPPLY-SIDE ANALYSIS), 2025
- FIGURE 51 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: COMPANY REVENUE ANALYSIS-BASED ESTIMATION (BOTTOM-UP APPROACH) (2025)
- FIGURE 52 ILLUSTRATIVE EXAMPLE OF THERMO FISHER SCIENTIFIC INC.: REVENUE ANALYSIS (2025)
- FIGURE 53 SEGMENTAL MARKET SIZE ESTIMATION: TOP-DOWN APPROACH
- FIGURE 54 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: CAGR PROJECTIONS
- FIGURE 55 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: DATA TRIANGULATION
02-2729-4219
+886-2-2729-4219
核酸萃取和純化市場：全球市場按產品類型、技術、樣品類型、應用和最終用戶分類的預測——2026-2032年
核酸分離純化市場規模、佔有率、趨勢和預測：按產品、類型、方法、最終用戶和地區分類，2026-2034年
2026年全球核酸萃取與純化市場報告
全球核酸分離純化市場規模、佔有率、趨勢及成長分析報告（2026-2034）
核酸分離純化市場：趨勢與預測（至 2035 年）－依產品類型、核酸種類、溶液類型、純化方法、樣品類型、製程、應用領域、最終用戶、地區及主要廠商劃分
核酸分離純化市場規模、佔有率和趨勢分析報告：按產品、類型、應用、方法、最終用途、地區和細分市場預測（2026-2033 年）北美核酸分離與精製市場：市場規模、佔有率、趨勢分析（按產品、類型、方法、應用、最終用途和地區）、細分市場預測（2025-2030 年）2024 年至 2031 年核酸分離和純化市場（按最終用戶、方法、核酸類型和地區劃分）